Precision Immunotherapy to Improve Sepsis Outcomes
This trial assessed whether immunotherapy tailored to individual immune dysregulation—macrophage activation–like syndrome and sepsis-induced immunoparalysis—could improve organ function among patients with sepsis-3.
Publication Details
- Journal
- JAMA
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1001/jama.2025.24250
- Primary Topic
- Sepsis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00